Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effect of vardenafil on endothelial function of brachial and cavernous arteries

International Journal of Impotence Research volume 18, pages 464–469 (2006)Cite this article

Abstract

The aim of the present study was to examine the effect of new phosphodiesterase type 5 inhibitor vardenafil on endothelial function of cavernous and brachial arteries in healthy men and in patients with different forms of erectile dysfunction (ED). This prospective, double-blind, placebo-controlled study was performed on 135 men with ED and 30 healthy controls. Complex evaluation was performed in all patients with ED. All participants also underwent our modification of ultrasound (US) assessment of postocclusive changes in the diameter of cavernosal arteries and endothelium-dependent flow-mediated dilation (FMD) of the brachial artery before and 1 h after administration of 20 mg of vardenafil or placebo. After study drug administration, PICAD and FMD significantly increased in patients receiving vardenafil (P<0.001) but not in patients receiving placebo. Increase in PICAD values was significantly greater in patients with arteriogenic ED compared with patients with organic nonarterial ED (P=0.007), psychogenic ED (P<0.001) and controls (P=0.001). The most prominent increase in brachial artery FMD values were found in patients with arteriogenic ED, although statistically significant differences were present only between patients with arteriogenic ED and control group (P=0.035). We have found a moderate negative correlation between initial PICAD and its increase after vardenafil and between pretreatment flow-mediated vasodilation of brachial arteries and its increase after vardenafil administration (r=−0.57 and −0.55, respectively). These findings suggest that the use of vardenafil restores impaired endothelial function of cavernous and brachial arteries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. NIH Consensus Development Conference Statement. NIH consensus development panel on impotence. Int J Impot Res 1993; 4: 181–284.

  2. Parazzini F, Menchini FF, Bortolotti A, Calabro A, Chatenoud L, Colli E et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–49.

    Article  CAS  PubMed  Google Scholar 

  3. Chew KK, Earle CM, Stuckey BG, Jamrozik K, Keogh EJ . Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000; 12: 41–45.

    Article  CAS  PubMed  Google Scholar 

  4. Roumeguere T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC . Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003; 44: 355–359.

    Article  PubMed  Google Scholar 

  5. Martin-Morales A, Sanches-Cruz J, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R . Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiologia de la disfuncion erectil masculina study. J Urol 2001; 166: 569–574.

    Article  CAS  PubMed  Google Scholar 

  6. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ . Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24 (Suppl 6): S17–S37.

    Article  CAS  PubMed  Google Scholar 

  7. Andersson KE, Wagner G . Physiology of penile erection. Physiol Rev 1995; 75: 191–236.

    Article  CAS  PubMed  Google Scholar 

  8. Francis SH, Corbin JD . Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists. Curr Urol Rep 2003; 4: 457–465.

    Article  PubMed  Google Scholar 

  9. Virag R . Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content. J Mal Vascul 2002; 27: 214–217.

    CAS  Google Scholar 

  10. Virag R, Floresco J, Richard C . Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction. Int J Impot Res 2004; 16: 39–42.

    Article  CAS  PubMed  Google Scholar 

  11. Mazo E, Gamidov S, Andranovich S, Iremashvili V . Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction. J Sex Med 2006 (in press; DOI:10.111/j.1743-6109.2005.00098.x).

  12. Verma S, Buchanan MR, Anderson TJ . Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054–2059.

    Article  PubMed  Google Scholar 

  13. Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S . Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 2000; 36: 845–851.

    Article  CAS  PubMed  Google Scholar 

  14. Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA . Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002; 25: 1336–1339.

    Article  CAS  PubMed  Google Scholar 

  15. Vlachopoulos C, Tsekoura D, Alexopoulos N, Panagiotakos D, Aznaouridis K, Stefanadis C . Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction. Am J Hypertens 2004; 17: 1040–1044.

    Article  CAS  PubMed  Google Scholar 

  16. Guazzi M, Tumminello G, Di Marco F, Guazzi MD . Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure. Clin Pharmacol Ther 2004; 76: 371–378.

    Article  CAS  PubMed  Google Scholar 

  17. Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G . Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214–220.

    Article  CAS  PubMed  Google Scholar 

  18. Dishy V, Sofowora G, Harris PA, Kandcer M, Zhan F, Wood AJ et al. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin Pharmacol Ther 2001; 70: 270–279.

    Article  CAS  PubMed  Google Scholar 

  19. Dishy V, Harris PA, Pierce R, Prasad HC, Sofowora G, Bonar HL et al. Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers. Br J Clin Pharmacol 2004; 57: 209–212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ . Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179–184.

    PubMed  Google Scholar 

  21. Halcox JPJ, Nour KRA, Zalos G, Mincemoyer R, Waclawiw MA, Rivera CE et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 2002; 40: 1232–1240.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Russian State Medical University, Moscow, Russia

    E Mazo, S Gamidov & V Iremashvili

Authors
  1. E Mazo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Gamidov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Iremashvili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Mazo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazo, E., Gamidov, S. & Iremashvili, V. The effect of vardenafil on endothelial function of brachial and cavernous arteries. Int J Impot Res 18, 464–469 (2006). https://doi.org/10.1038/sj.ijir.3901454

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901454

Keywords

This article is cited by

Search

Advanced search

Quick links